 CINCINNATI, July 23, 2021 GLOBE NEWSWIRE -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it signed a definitive agreement to acquire the North American BreathTek business from Otsuka America Pharmaceutical, Inc. for 20 million in cash. The transaction is expected to close in Meridians fiscal fourth quarter. 